Новини
01 Oct 2024
One company name, one culture and one way of working!
From 1 October 2024, all Ceres Pharma affiliates changed their local company name to Ceres Pharma.
15 Dec 2023
Ceres Pharma has reached an agreement to acquire Italian Aesculapius Farmaceutici
Ceres Pharma NV, a Belgian based pharmaceutical company, active in Women’s and Family Health, has reached an agreement to acquire 100% of the shares of the Italian pharmaceutical company Aesculapius Farmaceutici S.r.l.
05 Oct 2023
Ceres Pharma acquires Hungarian VitaPlus
Ceres Pharma NV, a Belgian based pharmaceutical company, active in Women’s and Family Health, has acquired the Hungarian pharmaceutical company VitaPlus Kft, including Innopharm Kft.
08 May 2023
Ceres Pharma acquires Italian Amnol group
Ceres Pharma NV, a Belgian based pharmaceutical company, active in Women and Family Healthcare, has acquired the Italian pharmaceutical group Amnol S.r.l.
06 Oct 2022
Ceres Pharma acquires Belgian Labophar
Ceres Pharma reached an agreement with Dovesco to acquire 100% of the shares of Labophar. Simultaneously Dovesco will re-invest its proceeds in Ceres Pharma.
03 Oct 2022
Ceres Pharma acquires Romanian Dacia Plant
Ceres Pharma, a Belgian based dynamic and fast growing pharmaceutical company, active in Women’s and Family Health, has come to an agreement for the acquisition of the Romanian firm Dacia Plant.
12 Nov 2021
Ceres Pharma acquires GlobiFer Intl.
Belgian based Ceres Pharma, a dynamic and fast growing pharmaceutical company, active in healthcare & well-being, has completed the acquisition of GlobiFer Intl.
12 Jul 2021
Naxicap Partners acquires Ceres Pharma
Naxicap Partners acquires Ceres Pharma NV from Alychlo NV & co-founder Mario Debel who will lead this new phase of growth as CEO and shareholder.
27 May 2021
Ceres Pharma acquires Bulgarian ABOPharma
Belgian based Ceres Pharma, a dynamic and fast-growing pharmaceutical company, active in healthcare & well-being, has completed the acquisition of the Bulgarian firm, ABOPharma. The price of the takeover will not be disclosed.